These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34019142)

  • 21. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte.
    Giersch K; Dandri M
    J Clin Transl Hepatol; 2015 Sep; 3(3):220-9. PubMed ID: 26623269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo.
    Giersch K; Bhadra OD; Volz T; Allweiss L; Riecken K; Fehse B; Lohse AW; Petersen J; Sureau C; Urban S; Dandri M; Lütgehetmann M
    Gut; 2019 Jan; 68(1):150-157. PubMed ID: 29217749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hepatitis delta virus: Replication and pathogenesis.
    Sureau C; Negro F
    J Hepatol; 2016 Apr; 64(1 Suppl):S102-S116. PubMed ID: 27084031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model.
    Sureau C
    Methods Mol Biol; 2010; 640():463-73. PubMed ID: 20645068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes.
    Lange F; Garn J; Anagho HA; Vondran FWR; von Hahn T; Pietschmann T; Carpentier A
    Liver Int; 2023 Oct; 43(10):2116-2129. PubMed ID: 37366005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes.
    Zhang Z; Filzmayer C; Ni Y; Sültmann H; Mutz P; Hiet MS; Vondran FWR; Bartenschlager R; Urban S
    J Hepatol; 2018 Jul; 69(1):25-35. PubMed ID: 29524530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models for the study of human hepatitis B and D virus infection: New insights and progress.
    Burwitz BJ; Zhou Z; Li W
    Antiviral Res; 2020 Oct; 182():104898. PubMed ID: 32758525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatitis D virus: viral cycle and new therapeutic approaches].
    Turon-Lagot V; Saviano A; Schuster C; Verrier ÉR
    Virologie (Montrouge); 2019 Jun; 23(3):149-159. PubMed ID: 31210131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.
    Huang CR; Lo SJ
    World J Gastroenterol; 2014 Oct; 20(40):14589-97. PubMed ID: 25356023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of in vivo hepatitis D virus infection.
    Goyal A; Murray JM
    J Theor Biol; 2016 Jun; 398():9-19. PubMed ID: 27012516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
    Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
    World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection.
    Buchmann B; Döhner K; Schirdewahn T; Sodeik B; Manns MP; Wedemeyer H; Ciesek S; von Hahn T
    Antiviral Res; 2017 May; 141():116-123. PubMed ID: 28223128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.